These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23253822)

  • 1. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
    Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
    Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
    Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
    PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
    Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
    J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
    Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
    Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
    Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
    Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J; Wang YJ; Liu L; Zhao YL
    J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
    Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
    Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
    Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation.
    Dong M; Spelke DP; Lee YK; Chung JK; Yu CH; Schaffer DV; Groves JT
    Biophys J; 2018 Sep; 115(5):865-873. PubMed ID: 30075851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity.
    Fan T; Liang B; Nie L; Wang J; Zhang H; Ciechanover A; Xu Y; An J; Huang Z
    Eur J Med Chem; 2022 Dec; 244():114804. PubMed ID: 36208510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
    Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C
    Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Significance of EphB4 Expression in Cancer.
    Ullah A; Razzaq A; Zhou C; Ullah N; Shehzadi S; Aziz T; Alfaifi MY; Elbehairi SEI; Iqbal H
    Curr Protein Pept Sci; 2024; 25(3):244-255. PubMed ID: 37909437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast.
    Gu X; Vedvyas Y; Chen X; Kaushik T; Hwang CI; Hu X; Nikitin AY; Jin MM
    PLoS One; 2012; 7(1):e30680. PubMed ID: 22292016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
    Bhatia S; Sharma J; Bukkapatnam S; Oweida A; Lennon S; Phan A; Milner D; Uyanga N; Jimeno A; Raben D; Somerset H; Heasley L; Karam SD
    Clin Cancer Res; 2018 Sep; 24(18):4539-4550. PubMed ID: 29848571
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.